219 results
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
(as defined below) do not constitute a majority of the Board (or, if applicable, the Board of Directors of a successor corporation to the Company … of this Plan by the Board or (y) who was
nominated or elected subsequent to such date by at least a majority of the directors who were Continuing Directors
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
9 Jan 24
Regulation FD Disclosure
8:40am
in the fair value of contingent consideration as the vast majority is non-deductible for tax purposes. The Company views these non-GAAP financial
S-8 POS
EBS
Emergent Biosolutions Inc
12 Dec 23
Registration of securities for employees (post-effective amendment)
7:05pm
indemnification (unless ordered by a court) shall be made only after a determination by a majority of disinterested directors, a committee of disinterested
S-8
fnufavx6ynews8fy6s9
11 Dec 23
Registration of securities for employees
5:22pm
8-K
EX-99.1
texse7p
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.2
bcbbu4
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-10.1
egc7m8 5y
2 Oct 23
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
7:49am
8-K
EX-99.1
bsi331it
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.2
h2ycdii96 2fdh2
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.1
jnunz
27 Jul 23
Departure of Directors or Certain Officers
4:48pm
S-8
EX-4.4
lht1z71x
5 Jun 23
Registration of securities for employees
5:31pm
S-8
EX-4.5
e4zrwdsnho9w35vxk
5 Jun 23
Registration of securities for employees
5:31pm
424B5
nq51l6yx k5c5
18 May 23
Prospectus supplement for primary offering
7:45am